𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant immunotherapy with transfer factor in patients with melanoma metastatic to lung

✍ Scribed by Raymond L. Gonzalez; Peter Wong; Lynn E. Spitler

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
686 KB
Volume
45
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant immunotherapy of primary resect
Adjuvant immunotherapy of primary resected lung cancer with transfer factor
✍ Takehiko Fujisawa; Yutaka Yamaguchi; Hideki Kimura; Masaaki Arita; Masayuki Baba πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 596 KB

One hundred seventy-one patients were studied in order to evaluate the clinical efficacy of the transfer factor (TF) for primary resected lung cancers under a randomized controlled trial. Eligible cases for evaluation were randomly chosen at 75 and 74 patients in TF and control groups, respectively.

Autoimmunity as a prognostic factor in m
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha
✍ Imke Satzger; Andre Meier; Florian Schenck; Alexander Kapp; Axel Hauschild; Ralf πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 114 KB

## Abstract Interferon alpha is used for the adjuvant treatment of malignant melanoma at different dosages (high‐, intermediate‐, low‐dose therapy). Only a minority of patients might benefit from this therapy, and markers to identify such patients are missing. A recent study suggested that melanoma